CA
AERI

Commerzbank Aktiengesellschaft’s Aerie Pharmaceuticals AERI Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-40,061
Closed -$707K – 1195
2015
Q2 		$707K Sell
40,061
-124,197
-76% -$2.28M ﹤0.01% 903
2015
Q1 		$5.15M Buy
+164,258
New +$4.76M 0.03% 358

Other funds holding AERI

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commerzbank Aktiengesellschaft's AERI Position: Q3 2015 in Review

Commerzbank Aktiengesellschaft sold out of Aerie Pharmaceuticals (AERI) in Q3 2015, closing a stake of 40,061 shares — an estimated $707K sold.

Commerzbank Aktiengesellschaft first reported a position in AERI in Q1 2015 and held it in 2 quarters. The position peaked at $5.15M in Q1 2015. 115 funds tracked by Wall St. Rank hold AERI as of Q3 2015.

  • Commerzbank Aktiengesellschaft reported no remaining Aerie Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 40,061 Aerie Pharmaceuticals shares in Q3 2015, an estimated $707K.
  • Commerzbank Aktiengesellschaft first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 2 quarters.
  • Commerzbank Aktiengesellschaft's Aerie Pharmaceuticals position peaked at $5.15M in Q1 2015.
  • 115 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2015.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2015, filed 29 Oct 2015.